Global, regional and national burden of atrial fibrillation and flutter attributable to metabolic risks from 1990 to 2021: analysis of data from the global burden of disease study, 2021

Back

EHRA Premium Access

Global, regional and national burden of atrial fibrillation and flutter attributable to metabolic risks from 1990 to 2021: analysis of data from the global burden of disease study, 2021

Session: Atrial fibrillation epidemiology and clinical outcome

Topic: Prevalence and Incidence of Atrial Fibrillation

Speaker: Doctor L. Ding (Beijing, CN)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Lei Ding

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

5 more presentations in this session

Major clinical outcomes in patients with symptomatic versus asymptomatic atrial fibrillation: a Bayesian and frequentist meta-analysis

Speaker: Doctor P. Karakasis (Thessaloniki, GR)

Regional disparities in the care and outcomes of atrial fibrillation patients in a universal health care system: a population-based cohort study

Speaker: Doctor M. Shurrab (Sudbury, CA)

Elevated red cell distribution width (RDW) and adverse outcomes in patients with atrial fibrillation: new insights from a contemporary prospective study

Speaker: Doctor M. Vitolo (Modena, IT)

Impact of early rhythm control in young and middle-aged patients with depression or anxiety and new-onset atrial fibrillation

Speaker: Doctor S. Lee (Seoul, KR)

Impact of atrial fibrillation on cardiac arrest: a nationwide cohort study

Speaker: Miss D. Rajan (Copenhagen, DK)

Access the full session

Atrial fibrillation epidemiology and clinical outcome

Speakers: Doctor L. Ding, Doctor P. Karakasis, Doctor M. Shurrab, Doctor M. Vitolo, Doctor S. Lee...

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources